Read + Share
Amedeo Smart
Independent Medical Education
Yang H, Li B, Guo Q, Tang J, et al. Systematic review with meta-analysis: loss of response and requirement of ustekinumab dose escalation in inflammatory bowel diseases. Aliment Pharmacol Ther 2022;55:764-777.PMID: 35141914
Email
LinkedIn
Facebook
Twitter
Privacy Policy